Evaluation of immune response of Hepatitis B vaccination in Zahedan infants

authors:

avatar Masoud Salehi 1 , * , avatar Esmail Sanei-Moghadam 2 , avatar Soheila Khosravi 2

Tropical and Infectious diseases dept, faculty of medicine, Zahedan university of medical sciences and health services, Zahedan, Iran.
South eastern center of blood transfusion, Zahedan, Iran.

how to cite: Salehi M, Sanei-Moghadam E, Khosravi S. Evaluation of immune response of Hepatitis B vaccination in Zahedan infants. Zahedan J Res Med Sci. 2002;4(3):e95321. 

Abstract

Hepatitis B vaccination is the best way of prevention of Hepatitis B infection and chronic
liver disease as well as hepatocellular carcinoma. Mass vaccination of Hepatitis B in neonate
has started in Iran since 1993. So evaluation of vaccination is essential. In this study,
seroconvertion of antiHBs evaluated after complete vaccination of Hepatitis in 15-23 month old
infants. 324 infants selected randomly from general population of Zahedan. The positivity rate
of antiHBs in male, female and total samples was 77%, 80% and 78.4, respectively. This ratio
was less than expected, so we suggest further study about this subject.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.

    The References of this article are available on the PDF file.